Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer’s disease

作者: Ravikumar Ponnusamy , M. Windy McNerney , Shahrzad Moghadam , Ahmad Salehi

DOI: 10.1016/J.BRAINRES.2017.09.035

关键词:

摘要: Abstract Building upon the knowledge that a number of important brain circuits undergo significant degeneration in Alzheimer’s disease, numerous recent studies suggest norepinephrine-ergic system brainstem undergoes alterations early course both disease and Down syndrome. Massive projections from locus coeruleus neurons to almost entire brain, extensive innervation capillaries, widespread distribution noradrenergic receptors enable play crucial role neural processes, including cognitive function. These anatomical functional characteristics support as an target for developing new therapies dysfunction. Careful neuropathological examinations using postmortem samples individuals with have implicated etiopathogenesis disease. Furthermore, supported existence strong interaction between neuroimmune systems. We explore two systems could disease-modifying effects norepinephrine

参考文章(133)
M Gautier, J Lejeune, R Turpin, Study of somatic chromosomes from 9 mongoloid children Comptes rendus hebdomadaires des séances de l'Académie des sciences. ,vol. 248, pp. 1721- 1722 ,(1959)
Guillermo Jaim-Etcheverry, 2-Chloroethylamines (DSP4 and Xylamine) Humana Press, Totowa, NJ. pp. 131- 140 ,(1998) , 10.1007/978-1-59259-477-1_5
Ahmad Salehi, Alexander Kleshevnikov, William C. Mobley, Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy Springer, New York, NY. pp. 64- 104 ,(2007) , 10.1007/978-0-387-71522-3_5
Yurika Ishii, Ayaka Yamaizumi, Ayu Kawakami, Afsana Islam, Mohammed E. Choudhury, Hisaaki Takahashi, Hajime Yano, Junya Tanaka, Anti-inflammatory effects of noradrenaline on LPS-treated microglial cells: Suppression of NFκB nuclear translocation and subsequent STAT1 phosphorylation. Neurochemistry International. ,vol. 90, pp. 56- 66 ,(2015) , 10.1016/J.NEUINT.2015.07.010
PW Mantyh, SD Rogers, CJ Allen, MD Catton, JR Ghilardi, LA Levin, JE Maggio, SR Vigna, Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human The Journal of Neuroscience. ,vol. 15, pp. 152- 164 ,(1995) , 10.1523/JNEUROSCI.15-01-00152.1995
Mollie K Meffert, Jolene M Chang, Brian J Wiltgen, Michael S Fanselow, David Baltimore, None, NF-κB functions in synaptic signaling and behavior Nature Neuroscience. ,vol. 6, pp. 1072- 1078 ,(2003) , 10.1038/NN1110
Suzanne E. Hickman, Joseph El Khoury, The neuroimmune system in Alzheimer's disease: the glass is half full. Journal of Alzheimer's Disease. ,vol. 33, ,(2012) , 10.3233/JAD-2012-129027
Michael T. Heneka, Elena Galea, Vitaliy Gavriluyk, Lucia Dumitrescu-Ozimek, JoAnna Daeschner, M. Kerry O'Banion, Guy Weinberg, Thomas Klockgether, Douglas L. Feinstein, Noradrenergic Depletion Potentiates β-Amyloid-Induced Cortical Inflammation: Implications for Alzheimer's Disease The Journal of Neuroscience. ,vol. 22, pp. 2434- 2442 ,(2002) , 10.1523/JNEUROSCI.22-07-02434.2002
Warren B. Zigman, Atypical aging in down syndrome Developmental Disabilities Research Reviews. ,vol. 18, pp. 51- 67 ,(2013) , 10.1002/DDRR.1128